Standards Comparison

    FISMA

    Mandatory
    2014

    U.S. law mandating risk-based federal cybersecurity programs

    VS

    FDA 21 CFR Part 11

    Mandatory
    1997

    FDA regulation for trustworthy electronic records and signatures

    Quick Verdict

    FISMA mandates risk-based cybersecurity for US federal agencies and contractors via NIST RMF, while FDA 21 CFR Part 11 ensures electronic records/signatures are trustworthy equivalents to paper for life sciences firms. Organizations adopt them for mandatory compliance and data integrity.

    Cybersecurity

    FISMA

    Federal Information Security Modernization Act of 2014

    Cost
    €€€€
    Complexity
    Medium
    Implementation Time
    18-24 months

    Key Features

    • Mandates NIST Risk Management Framework (RMF)
    • Requires continuous monitoring and diagnostics
    • Enforces FIPS 199 system categorization
    • Demands annual independent IG evaluations
    • Extends to agencies and contractors
    Electronic Records

    FDA 21 CFR Part 11

    21 CFR Part 11: Electronic Records; Electronic Signatures

    Cost
    €€€€
    Complexity
    High
    Implementation Time
    12-18 months

    Key Features

    • Secure, time-stamped audit trails for record changes
    • Unique electronic signatures with non-repudiation controls
    • Access limitation and authority checks for users
    • Closed and open system control distinctions
    • Risk-based validation with enforcement discretion

    Detailed Analysis

    A comprehensive look at the specific requirements, scope, and impact of each standard.

    FISMA Details

    What It Is

    The Federal Information Security Modernization Act (FISMA) of 2014 is a U.S. federal law that modernizes the 2002 FISMA, establishing a mandatory risk-based framework for protecting federal information and systems' confidentiality, integrity, and availability. It requires agencies to implement comprehensive security programs using the NIST Risk Management Framework (RMF), a 7-step process emphasizing continuous monitoring over static compliance.

    Key Components

    • **RMF stepsPrepare, Categorize (FIPS 199), Select/Implement/Assess (NIST SP 800-53 controls), Authorize, Monitor.
    • Continuous diagnostics and mitigation (CDM), incident reporting, SSPs, POA&Ms, ATOs.
    • Oversight via OMB policy, CISA operations, IG annual assessments using maturity models aligned to NIST CSF.

    Why Organizations Use It

    Federal agencies and contractors face legal mandates to avoid IG downgrades, contract losses, debarment. It reduces breach risks, enables federal market access, builds stakeholder trust, and aligns cybersecurity with mission resilience through evidence-based decisions.

    Implementation Overview

    Phased RMF execution: governance setup, asset inventory/categorization, control deployment, assessments, ongoing monitoring. Targets federal executive agencies, contractors handling federal data; requires automation, audits, scalable for enterprises to SMBs. (178 words)

    FDA 21 CFR Part 11 Details

    What It Is

    21 CFR Part 11, officially Electronic Records; Electronic Signatures, is an FDA regulation establishing criteria for electronic records and signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It targets FDA-regulated activities via a risk-based approach outlined in the 2003 guidance, applying narrowly to records relied upon instead of paper under predicate rules.

    Key Components

    • **Subpart AGeneral provisions, scope, definitions (closed/open systems).
    • **Subpart BControls for closed (§11.10: validation, audit trails, access) and open (§11.30: encryption, digital signatures) systems; signature manifestation/linking.
    • **Subpart CElectronic signatures (uniqueness, multi-component controls, ID/password security). Built on enduring principles like data integrity (ALCOA+); no formal certification—compliance demonstrated via FDA inspections.

    Why Organizations Use It

    Mandatory for pharma, devices, biotech using e-records; prevents warnings, holds, recalls. Drives data integrity, inspection readiness, operational efficiency, quality investigations, and digital transformation benefits.

    Implementation Overview

    Phased, risk-based CSV (GAMP5): scoping, gap analysis, IQ/OQ/PQ validation, SOPs, training, supplier governance. Applies to US life sciences; ongoing via change control, audits. (178 words)

    Key Differences

    Scope

    FISMA
    Federal info systems security, risk management
    FDA 21 CFR Part 11
    Electronic records/signatures trustworthiness

    Industry

    FISMA
    US federal agencies, contractors
    FDA 21 CFR Part 11
    Life sciences, pharma, medical devices

    Nature

    FISMA
    Mandatory federal law, risk framework
    FDA 21 CFR Part 11
    FDA regulation, equivalency criteria

    Testing

    FISMA
    Continuous monitoring, RMF assessments
    FDA 21 CFR Part 11
    System validation, IQ/OQ/PQ

    Penalties

    FISMA
    Contract loss, debarment, IG reports
    FDA 21 CFR Part 11
    Warning letters, product holds

    Frequently Asked Questions

    Common questions about FISMA and FDA 21 CFR Part 11

    FISMA FAQ

    FDA 21 CFR Part 11 FAQ

    You Might also be Interested in These Articles...

    Run Maturity Assessments with GRADUM

    Transform your compliance journey with our AI-powered assessment platform

    Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

    100+ Standards & Regulations
    AI-Powered Insights
    Collaborative Assessments
    Actionable Recommendations

    Check out these other Gradum.io Standards Comparison Pages